Cargando…
Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
BACKGROUND: The aim of this study was to determine whether long-term intermittent azithromycin therapy reduces the frequency of exacerbation in severe chronic obstructive pulmonary disease (COPD). METHODS: We retrospectively investigated the clinical benefits of long-term azithromycin (500 mg orally...
Autores principales: | Pomares, Xavier, Montón, Concepción, Espasa, Mateu, Casabon, Jordi, Monsó, Eduard, Gallego, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186743/ https://www.ncbi.nlm.nih.gov/pubmed/22003290 http://dx.doi.org/10.2147/COPD.S23655 |
Ejemplares similares
-
Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors
por: Gallego, Miguel, et al.
Publicado: (2014) -
C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity
por: Gallego, Miguel, et al.
Publicado: (2016) -
Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To Pseudomonas aeruginosa: A Retrospective Cohort Study
por: Montón, Concepción, et al.
Publicado: (2019) -
Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa
por: Millares, L., et al.
Publicado: (2014) -
Functional Metagenomics of the Bronchial Microbiome in COPD
por: Millares, Laura, et al.
Publicado: (2015)